• These models differ in complexity and resource requirements, but both target education to AA at risk for nonvaccination in a familiar, trusted, and accessible environment.
INTRODUCTION REDUCING DISPARITIES IN U.S. VACCINATION THROUGH SENIOR CENTERS: A COMPARISON OF THREE EDUCATIONAL MODELS FOR OLDER AFRICAN AMERICANS
• Vaccination for preventable diseases is a high-value healthcare intervention, yet rates remain below US Centers for Disease Control and Prevention (CDC) benchmarks, especially among minorities. 1,2 • The complex American healthcare system is difficult to navigate, contributing to underuse of vaccination.
• Decreased trust in the system resulting from a history of discrimination further exacerbates low vaccination rates (VR) among African Americans (AA) in particular. [3] [4] [5] [6] • Senior centers (SC) are an accessible, trusted venue for AA, presenting an opportunity to increase VR.
To describe the evolution of three innovative vaccine education models developed in partnership with a nationally accredited Philadelphia SC.
CONCLUSIONS
• These educational models were specifically designed to appeal to older AA; thus, they may be less effective in other populations.
• PHARM, PEER, and PHARM+PEER represent novel, culturally appropriate educational interventions that draw on SC strengths to reach an older AA population.
• Operationalizing vaccination education through SC is a novel approach which US healthcare policymakers should consider to increase VR.
• Future work will elucidate the comparative effectiveness of PHARM and PEER versus PHARM+PEER. 
FUNDING DISCLOSURE

RESULTS
Logistics:
o Limit program duration to 1.5 hours o Provide refreshments and/or a modest giveaway o Call participants 1-2 days before the program to remind them o Pharmacy students can be leveraged to help staff program events • Equal partnership between the community, SC, and pharmacists was a key success factor • Though PPPP was successful in improving participants' knowledge and beliefs about pneumococcal disease, it was expensive to implement, in large part due to the cost of supplying and storing the vaccine. 7, 8 • Planned testing using a randomized controlled trial (RCT) to compare the PHARM and PEER approaches is currently in development for a vaccination education program covering influenza, pneumonia, and zoster. o Intervention will be delivered to 316 older AA (158 in each arm) in 10 urban SC sites across the Delaware Valley (Pennsylvania, New Jersey, and Delaware). o Program focus will be education about vaccine-preventable diseases; thus, vaccination will not be offered, potentially reducing the cost of the program. o Outcomes will be assessed using a standardized knowledge instrument adapted from PPPP, which will allow comparison of PHARM and PEER results to the PHARM+PEER (PPPP) results. 
RESULTS (continued)
•
